In the context of HCC, analysis of patient secretomes derived from cancer and adjacent normal tissues using integrative transcriptomics and proteomics identified chitinase‐3‐like protein 1 (CHI3L1) and MASP2 as biomarkers in HCC diagnosis. The gene discussed is CHI3L1; the disease is hepatocellular carcinoma.